banner HPMU
TRA CỨU
Thư mục - Vốn tư liệu
Comparison of methylprednisolone alone versus intravenous immunoglobulin plus methylprednisolone for multisystem inflammatory syndrome in children (MIS-C)

Comparison of methylprednisolone alone versus intravenous immunoglobulin plus methylprednisolone for multisystem inflammatory syndrome in children (MIS-C)

 BMJ 2025
 Eng
Mô tả biểu ghi
ID:34054
NLM C22
Tác giả CN Phan Hữu Phúc
Nhan đề Comparison of methylprednisolone alone versus intravenous immunoglobulin plus methylprednisolone for multisystem inflammatory syndrome in children (MIS-C)
Thông tin xuất bản 2025
Thông tin xuất bản BMJ
Tóm tắt We included 391 patients, comprising 255 boys and 136 girls, who fulfilled the MIS-C case definition of the US Centers for Disease Control and Prevention. Most patients (80.8%) received intravenous methylprednisolone monotherapy, and 19.2% were administered IVIG in addition to methylprednisolone. In general, the laboratory values indicative of hyperinflammatory and hyperthrombotic states displayed significant early response within 2–3 days after initial treatment, including white cell count (SE=1.77, p<0.001), NEU (SE=0.76, p=0.03), C reactive protein (SE=−46.51, p<0.001), PLT (SE=38.05, p=0.002), fibrinogen (SE=−0.37, p=0.002), d-dimer (SE=−849.8, p=0.02)); while subsequent improvement in cardiac markers was also observed, with pro-B-type natriuretic peptide (SE=−165.2, p<0.001) on day 5 and troponin I (SE=−0.05, p=0.004) on day 7. After propensity score weighting, there were 41 patients in each treatment group. Notably, there were no significant differences in the incidence of cardiac events between treatment groups regarding left ventricular dysfunction and coronary artery dilation or aneurysms (10.3% vs 20.7%, p=0.074 and 63.4% vs 56.1%, p=0.653, respectively)
Thuật ngữ chủ đề Pediatric
Từ khóa tự do Multisystem inflammatory syndrome; children
Địa chỉ 100Kho Bài báo quốc tế(1): BQT00124
Tệp tin điện tử https://doi.org/10.1136/bmjpo-2024-003148
Tệp tin điện tử https://lib.hpmu.edu.vn/kiposdata2/tapchi2026/anhbiatc/biabbqt_thumbimage.jpg
MARC
Hiển thị đầy đủ trường & trường con
TagGiá trị
00000000nab#a2200000ui#4500
00134054
00213
004B8255314-BEBA-4EAD-9EF6-ED3413536B2C
005202605201445
008081223s2025 vm| vie
0091 0
039[ ] |y 20260520144557 |z phuongntt
041[ ] |a Eng
084[ ] |a C22
100[ ] |a Phan Hữu Phúc
245[ ] |a Comparison of methylprednisolone alone versus intravenous immunoglobulin plus methylprednisolone for multisystem inflammatory syndrome in children (MIS-C)
260[ ] |c 2025
260[ ] |b BMJ
520[ ] |a We included 391 patients, comprising 255 boys and 136 girls, who fulfilled the MIS-C case definition of the US Centers for Disease Control and Prevention. Most patients (80.8%) received intravenous methylprednisolone monotherapy, and 19.2% were administered IVIG in addition to methylprednisolone. In general, the laboratory values indicative of hyperinflammatory and hyperthrombotic states displayed significant early response within 2–3 days after initial treatment, including white cell count (SE=1.77, p<0.001), NEU (SE=0.76, p=0.03), C reactive protein (SE=−46.51, p<0.001), PLT (SE=38.05, p=0.002), fibrinogen (SE=−0.37, p=0.002), d-dimer (SE=−849.8, p=0.02)); while subsequent improvement in cardiac markers was also observed, with pro-B-type natriuretic peptide (SE=−165.2, p<0.001) on day 5 and troponin I (SE=−0.05, p=0.004) on day 7. After propensity score weighting, there were 41 patients in each treatment group. Notably, there were no significant differences in the incidence of cardiac events between treatment groups regarding left ventricular dysfunction and coronary artery dilation or aneurysms (10.3% vs 20.7%, p=0.074 and 63.4% vs 56.1%, p=0.653, respectively)
650[ ] |a Pediatric
653[ ] |a Multisystem inflammatory syndrome
653[ ] |a children
691[ ] |a CTĐT Tiến sĩ Nhi khoa
691[ ] |a CTĐT Bác sĩ nội trú Nhi khoa
773[ ] |t BMJ Paediatr Open
852[ ] |a 100 |b Kho Bài báo quốc tế |j (1): BQT00124
856[ ] |u https://doi.org/10.1136/bmjpo-2024-003148
856[1 ] |u https://lib.hpmu.edu.vn/kiposdata2/tapchi2026/anhbiatc/biabbqt_thumbimage.jpg
890[ ] |a 1 |b 0 |c 0 |d 0
Dòng Mã vạch Bản sao Nơi lưu Tình trạng Cho phép yêu cầu
1 BQT00124 1 Kho Bài báo quốc tế
#1 BQT00124
Nơi lưu Kho Bài báo quốc tế
Tình trạng
Bình luận